Nanoparticles in Drug Delivery and Environmental Exposure: Same Size, Same Risks?
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Engineered nanoparticles are an important tool for future nanomedicines to deliver and target drugs or bring imaging agents to the targets where they are required. Since the original application of liposomes in the 1970s, a wealth of carrier and imaging systems has been developed, including magnetoliposomes, dendrimers, fullerenes and polymer carriers. However, to make use of this potential, toxicological issues must be addressed, in particular because of findings on combustion-derived nanoparticles in environmentally exposed populations, which show effects in those with respiratory or cardiovascular diseases. These effects are mediated by oxidative stress, lung and systemic inflammation and different mechanisms of internalization and translocation. Many effects found with combustion-derived nanoparticles have now tested positive with engineered nanoparticles, such as single-wall nanotubes. This article aims to identify common concepts in the action of nanoparticles in order to enable future cross-talk and mutual use of concepts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558 · cited 4×
“NPs as drug-delivery tools Drug delivery and related pharmaceutical development provide tools that consist of at least two components, one of which is an active ingredient [3,8].”
BackgroundInfluentialTranslocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Pope, C. A., Burnett, R. T., Thurston, G. D., Thun, M. J., Calle, E. E., Krewski, D., & Godleski, J. J. (2004) · Circulation · doi:10.1161/01.cir.0000108927.80044.7f · Cited by 2,592
Oberdörster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., Ausman, K., Carter, J., Karn, B., Kreyling, W., Lai, D., et al. (2005) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-2-8 · Cited by 2,134
Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage
Li, N., Sioutas, C., Cho, A., Schmitz, D., Misra, C., Sempf, J., Wang, M., Oberley, T., Froines, J., & Nel, A. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6000 · Cited by 2,097 · cited 2×
“drial function Ambient NP [53]”
BackgroundPassage of inhaled particles into the blood circulation in humans
Nemmar, A., Hoet, P. H. M., Vanquickenborne, B., Dinsdale, D., Thomeer, M., Hoylaerts, M. F., Vanbilloen, H., Mortelmans, L., & Nemery, B. (2002) · Circulation · doi:10.1161/hc0402.104118 · Cited by 1,719 · cited 3×
“ystemic circulation upon inhalation and instillation Specific NP, dependent on surface coating [36–39]”
BackgroundMethodUnusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice
Shvedova, A. A., Kisin, E. R., Mercer, R., Murray, A. R., Johnson, V. J., Potapovich, A. I., Tyurina, Y. Y., Gorelik, O., Arepalli, S., Schwegler-Berry, D., et al. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00084.2005 · Cited by 1,312 · cited 1×
“Several studies using intratracheal instillation of high doses of nanotubes in rodents demonstrated chronic lung inflammation, including foreign-body granuloma formation and interstitial fibrosis [29–31].”
BackgroundDonaldson, K., Aitken, R., Tran, L., Stone, V., Duffin, R., Forrest, G., & Alexander, A. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj130 · Cited by 1,167 · cited 2×
“The toxicology of carbon nanotubes was reviewed recently [25], with a brief summary here.”
BackgroundRespiratory toxicity of multi-wall carbon nanotubes
Muller, J., Huaux, F., Moreau, N., Misson, P., Heilier, J.-F., Delos, M., Arras, M., Fonseca, A., Nagy, J. B., & Lison, D. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.008 · Cited by 1,123 · cited 1×
“Several studies using intratracheal instillation of high doses of nanotubes in rodents demonstrated chronic lung inflammation, including foreign-body granuloma formation and interstitial fibrosis [29–31].”
BackgroundC. L. Tran, D. B. (2000) · Inhalation Toxicology · doi:10.1080/08958370050166796 · Cited by 436
Cited by
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Assessment of the In Vivo Toxicity of Gold Nanoparticles
Chen, Y.-S., Hung, Y.-C., Liau, I., & Huang, G. S. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9334-6 · Cited by 695
Nanotoxicology: An Interdisciplinary Challenge
Krug, H. F., & Wick, P. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201001037 · Cited by 556
Advances in PEGylation of important biotech molecules: delivery aspects
Ryan, S. M., Mantovani, G., Wang, X., Haddleton, D. M., & Brayden, D. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.4.371 · Cited by 323
Nanoparticles and Neurotoxicity
Win-Shwe, T.-T., & Fujimaki, H. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12096267 · Cited by 296
Metadata
- Authors
- Borm, P. J., & Müller-Schulte, D.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2006-08
- Volume
- 1
- Issue
- 2
- Pages
- 235-249
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2102429044
- Cited by
- 107
- References
- 10
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.